OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

Registration number of additiveName and registration number of person responsible for putting additive into circulationAdditive(trade name)Composition, chemical formula, descriptionSpecies or category of animalMaximum ageMinimum contentMaximum contentOther provisionsEnd of period of authorisationProvisional maximum residue limits (MRLs) in the relevant foodstuffs of animal origin
mg of active substance/kg of complete feedingstuff
Coccidiostats and other medicinal substances
‘E 757Eli Lilly and Company LimitedMonensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200)
  • Active substanc:

    C36H61O11Na

    sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis, ATCC 15413 in granular form.

    Factor composition:

    • Monensin A: not less than 90 %

    • Monensin: A + B: not less than 95 %

  • Additive composition:

    Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w

    Mineral oil 1-3 % w/w

    Limestone granular 13-23 % w/w

    Rice hulls or limestone granular qs 100 % w/w

    Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w

    Mineral oil 1-3 % w/w

    Rice hulls or limestone granular qs 100 % w/w

Chickens for fattening—100125

Use prohibited at least three days before slaughter. Indicate in the instructions for use:

“Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances”

30.7.2014

25 μg monensin sodium/kg of wet skin + fat.

8 μg monensin sodium/kg of wet liver, kidney and muscle’.

Chickens reared for laying16 weeks100120
Turkeys16 weeks60100